Virpax Pharmaceuticals Inc (VRPX)
0.7037
-0.01
(-0.89%)
USD |
NASDAQ |
Jun 13, 16:00
Virpax Pharmaceuticals Enterprise Value: 0.0631M for June 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 13, 2024 | 0.0631M |
| June 12, 2024 | 0.0804M |
| June 11, 2024 | 0.0944M |
| June 10, 2024 | 0.0884M |
| June 07, 2024 | 0.1903M |
| June 06, 2024 | 0.3285M |
| June 05, 2024 | 0.1106M |
| June 04, 2024 | 0.0612M |
| June 03, 2024 | 0.0804M |
| May 31, 2024 | -0.3903M |
| May 30, 2024 | -0.3326M |
| May 29, 2024 | -0.3275M |
| May 28, 2024 | -0.3671M |
| May 24, 2024 | -0.3378M |
| May 23, 2024 | -0.3482M |
| May 22, 2024 | -0.369M |
| May 21, 2024 | -0.306M |
| May 20, 2024 | -0.2362M |
| May 17, 2024 | -0.2195M |
| May 16, 2024 | -0.9292M |
| May 15, 2024 | -0.9526M |
| May 14, 2024 | 0.8159M |
| May 13, 2024 | 1.694M |
| May 10, 2024 | 1.120M |
| May 09, 2024 | 1.050M |
| Date | Value |
|---|---|
| May 08, 2024 | 0.8979M |
| May 07, 2024 | 0.6637M |
| May 06, 2024 | 0.8393M |
| May 03, 2024 | 0.7574M |
| May 02, 2024 | 0.7456M |
| May 01, 2024 | 1.109M |
| April 30, 2024 | 1.238M |
| April 29, 2024 | 1.378M |
| April 26, 2024 | 1.765M |
| April 25, 2024 | 1.552M |
| April 24, 2024 | 1.847M |
| April 23, 2024 | 1.835M |
| April 22, 2024 | 1.999M |
| April 19, 2024 | 2.444M |
| April 18, 2024 | 2.866M |
| April 17, 2024 | 2.198M |
| April 16, 2024 | 2.198M |
| April 15, 2024 | 2.269M |
| April 12, 2024 | 2.292M |
| April 11, 2024 | 2.362M |
| April 10, 2024 | 2.420M |
| April 09, 2024 | 2.245M |
| April 08, 2024 | 2.526M |
| April 05, 2024 | 2.690M |
| April 04, 2024 | 2.924M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-16.50M
Minimum
May 24 2022
104.19M
Maximum
Aug 18 2021
-0.0076M
Average
-5.218M
Median
Jan 04 2024
Enterprise Value Benchmarks
| SINTX Technologies Inc | -2.630M |
| BioCryst Pharmaceuticals Inc | 1.759B |
| Nortech Systems Inc | 32.76M |
| Bolt Biotherapeutics Inc | -61.87M |
| Coya Therapeutics Inc | 82.13M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.220M |
| Total Expenses (Quarterly) | 3.302M |
| EPS Diluted (Quarterly) | -2.75 |
| Earnings Yield | -2.05K% |